Cite Filings / LXEO / 0000902664-24-001520
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Lexeo Therapeutics, Inc. · Filed 2024-02-14 · Acc 0000902664-24-001520

Documents 1

  • SC 13G Amended Statement of Ownership , p24-0680sc13g.htm

Around this filing

  • 2024-02-14 SC 13G Amended Statement of Ownership
  • 2024-02-14 SC 13G Amended Statement of Ownership
  • 2024-02-14 SC 13G/A Amended Statement of Ownership
  • 2024-02-14 SC 13G Amended Statement of Ownership
  • 2024-02-14 SC 13G Amended Statement of Ownership
  • 2024-02-13 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 7.2%
  2. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 9.99%
  3. 2026-11-16 SCHEDULE 13G/A · Paradigm BioCapital Advisors LP 0.0%
  4. 2026-11-16 SCHEDULE 13G/A · OrbiMed Advisors LLC 3.9%
  5. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.3%
  6. 2026-11-13 SCHEDULE 13G/A · Affinity Asset Advisors, LLC 9.8%
Loading p24-0680sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…